[Studies on properdin. II. Chemicophysical characterization of properdin]. 1960

L CONTU, and R MARCOLONGO, and L LENZERINI

UI MeSH Term Description Entries
D011414 Properdin A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections. Complement Factor P,Factor P, Complement

Related Publications

L CONTU, and R MARCOLONGO, and L LENZERINI
January 1966, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete,
L CONTU, and R MARCOLONGO, and L LENZERINI
May 1957, The Journal of experimental medicine,
L CONTU, and R MARCOLONGO, and L LENZERINI
April 1960, Svenska lakartidningen,
L CONTU, and R MARCOLONGO, and L LENZERINI
January 1958, Problemy gematologii i perelivaniia krovi,
L CONTU, and R MARCOLONGO, and L LENZERINI
September 1961, Nihon saikingaku zasshi. Japanese journal of bacteriology,
L CONTU, and R MARCOLONGO, and L LENZERINI
January 1961, Acta haematologica,
L CONTU, and R MARCOLONGO, and L LENZERINI
June 1959, Zeitschrift fur Immunitatsforschung und experimentelle Therapie,
L CONTU, and R MARCOLONGO, and L LENZERINI
October 1961, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
L CONTU, and R MARCOLONGO, and L LENZERINI
October 1959, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!